HER4 overexpression in ER-positive breast cancer cells results in enhanced cell growth and estrogen response element (ERE)-mediated transcriptional activity, and ectopically expressed as well as endogenous HER4 interacts with ligand-bound ER in response to estrogen and potentiates ER transactivation [13,14]. The gene discussed is ESR1; the disease is breast cancer.